Latest filing published 20 Sept 2021 for Magenta Therapeutics, Inc., €33k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lisa Olson: trading record in brief
Lisa Olson is a declared insider of Dianthus Therapeutics, Inc. /DE/ (board member), with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 14 September 2021 to 16 September 2021.
On the market, this insider has only sold: 1 sale, €33k in total. Other entries cover 1 share grant.
On 20 September 2021 came the latest disclosure, an open-market sale for €33k in Dianthus Therapeutics, Inc. /DE/. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lisa Olson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,736 shares@ US$6.73100.0% of flowCommon StockSEC:0000899243-21-036596:0
- 20,000 shares0Common StockSEC:0000899243-21-036342:0
2 of 2 declarations
